Related Experiment Video
Updated: Apr 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug repositioning by integrating target information through a heterogeneous network model
Wenhui Wang1, Sen Yang2, Xiang Zhang2
1Department of Electrical Engineering and Computer Science, Case Western Reserve University, Cleveland, OH 44106, USA and Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA Department of Electrical Engineering and Computer Science, Case Western Reserve University, Cleveland, OH 44106, USA and Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA.
This study introduces a novel computational framework for drug repositioning using network medicine. The approach enhances drug discovery by analyzing complex relationships between diseases, drugs, and targets, outperforming existing methods.
Area of Science:
- Network medicine
- Computational biology
- Pharmacology
Background:
- Network medicine offers insights into disease complexity and aids in identifying new drug targets.
- Computational approaches integrate multi-source data for a systems-level understanding of drug-disease relationships.
Purpose of the Study:
- To propose a novel computational framework for drug repositioning.
- To leverage heterogeneous network models and omics data for enhanced drug discovery.
Main Methods:
- Developed a computational framework using a heterogeneous network model.
- Applied an iterative algorithm on a heterogeneous graph incorporating drug-target information to calculate disease-drug pair strength.
Main Results:
- The proposed framework significantly outperforms several recent drug repositioning approaches.
- Experimental results demonstrate the practical utility of the approach through case studies.
Conclusions:
- The novel computational framework provides a powerful tool for drug repositioning.
- This systems-level approach advances the understanding and treatment of complex diseases.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Drug Discovery: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...